Drugs / Pneumo Novum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00562939 Comparator | Jan 2008 → Jan 2009 | HIV infectious disease | University of Aarhus | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumo Novum | “Day 0: 1 ml Prevenar (double dose) + 1 mg CpG 7909, IM Day 90: 1 ml Prevenar (double dose) + 1 mg CpG 7909, IM Day 270: 0.5 ml Pneumo Novum + 1 mg CpG 7909, IM” NCT00562939 ↗ |
| Known as | PPV-23 | “1 dose of 23-valent pneumococcal polysaccharide vaccine (PPV-23; Pneumo Novum) at 9 months” PMID 20504165 ↗ Jul 2010 |
| Modality | Vaccine | “23-valent pneumococcal polysaccharide vaccine (PPV-23; Pneumo Novum)” PMID 20504165 ↗ Jul 2010 |
| Route | Intramuscular | “Day 0: 1 ml Prevenar (double dose) + 1 mg CpG 7909, IM Day 90: 1 ml Prevenar (double dose) + 1 mg CpG 7909, IM Day 270: 0.5 ml Pneumo Novum + 1 mg CpG 7909, IM” NCT00562939 ↗ |